Logo image of EB

EVENTBRITE INC-CLASS A (EB) Stock Fundamental Analysis

NYSE:EB - New York Stock Exchange, Inc. - US29975E1091 - Common Stock - Currency: USD

2.51  +0.01 (+0.4%)

After market: 2.54 +0.03 (+1.2%)

Fundamental Rating

3

EB gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 72 industry peers in the Entertainment industry. EB scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. EB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

EB had negative earnings in the past year.
EB had a positive operating cash flow in the past year.
In the past 5 years EB always reported negative net income.
EB had a positive operating cash flow in 4 of the past 5 years.
EB Yearly Net Income VS EBIT VS OCF VS FCFEB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M

1.2 Ratios

EB has a Return On Assets of -2.18%. This is comparable to the rest of the industry: EB outperforms 55.56% of its industry peers.
The Return On Equity of EB (-10.21%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -2.18%
ROE -10.21%
ROIC N/A
ROA(3y)-3.72%
ROA(5y)-10.96%
ROE(3y)-18.74%
ROE(5y)-41.86%
ROIC(3y)N/A
ROIC(5y)N/A
EB Yearly ROA, ROE, ROICEB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

EB has a better Gross Margin (68.73%) than 80.56% of its industry peers.
In the last couple of years the Gross Margin of EB has grown nicely.
The Profit Margin and Operating Margin are not available for EB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.73%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.76%
GM growth 5Y2.88%
EB Yearly Profit, Operating, Gross MarginsEB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150 -200

More info and screens

4

2. Health

2.1 Basic Checks

EB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, EB has less shares outstanding
Compared to 5 years ago, EB has more shares outstanding
EB has a better debt/assets ratio than last year.
EB Yearly Shares OutstandingEB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
EB Yearly Total Debt VS Total AssetsEB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

EB has an Altman-Z score of -0.68. This is a bad value and indicates that EB is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.68, EB is not doing good in the industry: 73.61% of the companies in the same industry are doing better.
EB has a debt to FCF ratio of 9.61. This is a negative value and a sign of low solvency as EB would need 9.61 years to pay back of all of its debts.
The Debt to FCF ratio of EB (9.61) is better than 61.11% of its industry peers.
A Debt/Equity ratio of 1.22 is on the high side and indicates that EB has dependencies on debt financing.
EB's Debt to Equity ratio of 1.22 is on the low side compared to the rest of the industry. EB is outperformed by 68.06% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF 9.61
Altman-Z -0.68
ROIC/WACCN/A
WACC6.42%
EB Yearly LT Debt VS Equity VS FCFEB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 1.45 indicates that EB should not have too much problems paying its short term obligations.
EB's Current ratio of 1.45 is fine compared to the rest of the industry. EB outperforms 63.89% of its industry peers.
EB has a Quick Ratio of 1.45. This is a normal value and indicates that EB is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.45, EB is in the better half of the industry, outperforming 68.06% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.45
Quick Ratio 1.45
EB Yearly Current Assets VS Current LiabilitesEB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

EB shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
EB shows a decrease in Revenue. In the last year, the revenue decreased by -6.52%.
EB shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.11% yearly.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40%
Revenue 1Y (TTM)-6.52%
Revenue growth 3Y20.22%
Revenue growth 5Y-0.11%
Sales Q2Q%-14.4%

3.2 Future

The Earnings Per Share is expected to grow by 22.76% on average over the next years. This is a very strong growth
EB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.11% yearly.
EPS Next Y-48.44%
EPS Next 2Y2.26%
EPS Next 3Y-1.97%
EPS Next 5Y22.76%
Revenue Next Year-7.59%
Revenue Next 2Y1.57%
Revenue Next 3Y4.93%
Revenue Next 5Y4.11%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EB Yearly Revenue VS EstimatesEB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M
EB Yearly EPS VS EstimatesEB Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2029 2030 0 -0.5 -1 -1.5 -2 -2.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EB. In the last year negative earnings were reported.
Also next year EB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EB Price Earnings VS Forward Price EarningsEB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150 200 250

4.2 Price Multiples

EB's Price/Free Cash Flow ratio is rather cheap when compared to the industry. EB is cheaper than 88.89% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.59
EV/EBITDA N/A
EB Per share dataEB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.26%
EPS Next 3Y-1.97%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EVENTBRITE INC-CLASS A

NYSE:EB (7/23/2025, 7:00:00 PM)

After market: 2.54 +0.03 (+1.2%)

2.51

+0.01 (+0.4%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-07 2025-08-07
Inst Owners81.82%
Inst Owner Change0.16%
Ins Owners5.82%
Ins Owner Change22.67%
Market Cap240.68M
Analysts45
Price Target3.26 (29.88%)
Short Float %5.69%
Short Ratio6.42
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-20.02%
Min EPS beat(2)-64.87%
Max EPS beat(2)24.82%
EPS beat(4)3
Avg EPS beat(4)37.02%
Min EPS beat(4)-64.87%
Max EPS beat(4)118.39%
EPS beat(8)6
Avg EPS beat(8)35.4%
EPS beat(12)8
Avg EPS beat(12)28.4%
EPS beat(16)11
Avg EPS beat(16)22.87%
Revenue beat(2)0
Avg Revenue beat(2)-2.29%
Min Revenue beat(2)-2.55%
Max Revenue beat(2)-2.02%
Revenue beat(4)0
Avg Revenue beat(4)-2.5%
Min Revenue beat(4)-5.02%
Max Revenue beat(4)-0.39%
Revenue beat(8)0
Avg Revenue beat(8)-2.62%
Revenue beat(12)1
Avg Revenue beat(12)-2.15%
Revenue beat(16)4
Avg Revenue beat(16)-0.15%
PT rev (1m)0%
PT rev (3m)-30.93%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-8.14%
EPS NY rev (1m)0%
EPS NY rev (3m)18.87%
Revenue NQ rev (1m)-1.6%
Revenue NQ rev (3m)-3.78%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.14%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.77
P/FCF 9.59
P/OCF 7.64
P/B 1.39
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.19
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)0.26
FCFY10.42%
OCF(TTM)0.33
OCFY13.1%
SpS3.26
BVpS1.81
TBVpS-0.04
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.18%
ROE -10.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 68.73%
FCFM 8.02%
ROA(3y)-3.72%
ROA(5y)-10.96%
ROE(3y)-18.74%
ROE(5y)-41.86%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.76%
GM growth 5Y2.88%
F-Score5
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 1.22
Debt/FCF 9.61
Debt/EBITDA N/A
Cap/Depr 41.41%
Cap/Sales 2.06%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.45
Quick Ratio 1.45
Altman-Z -0.68
F-Score5
WACC6.42%
ROIC/WACCN/A
Cap/Depr(3y)45.61%
Cap/Depr(5y)35.63%
Cap/Sales(3y)2.15%
Cap/Sales(5y)2.75%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-40%
EPS Next Y-48.44%
EPS Next 2Y2.26%
EPS Next 3Y-1.97%
EPS Next 5Y22.76%
Revenue 1Y (TTM)-6.52%
Revenue growth 3Y20.22%
Revenue growth 5Y-0.11%
Sales Q2Q%-14.4%
Revenue Next Year-7.59%
Revenue Next 2Y1.57%
Revenue Next 3Y4.93%
Revenue Next 5Y4.11%
EBIT growth 1Y2.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year154.24%
EBIT Next 3Y46.86%
EBIT Next 5Y28.19%
FCF growth 1Y3036.25%
FCF growth 3Y-29.09%
FCF growth 5Y12.63%
OCF growth 1Y400.35%
OCF growth 3Y-23.38%
OCF growth 5Y4.42%